A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
about
Stable isotope-resolved metabolomics and applications for drug developmentCholine Metabolism Alteration: A Focus on Ovarian CancerThe human plasma lipidomeCholine kinase and its functionExpression of microRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of Rosemary diterpenes in colon and pancreatic cancerFunctional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferationA new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.Lipidomic assessment of plasma and placenta of women with early-onset preeclampsia.Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanineCombined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment.Choline metabolism in malignant transformation.Characterization of human bladder cell membrane during cancer transformation.Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-α and therapeutic targeting.Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.Phosphorylation of Human Choline Kinase Beta by Protein Kinase A: Its Impact on Activity and Inhibition.Characterization of choline kinase in human endothelial cells.A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation.Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors.MR evaluation of response to targeted treatment in cancer cells.Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics.Sensitization of (colon) cancer cells to death receptor related therapies: a report from the FP6-ONCODEATH research consortium.Targeted therapies in bladder cancer: an overview of in vivo research.Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival.New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1.A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival.Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.1H, 13C NMR studies of new 3-aminophenol isomers linked to pyridinium salts.One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
P2860
Q24629149-2961DF36-1403-4135-B3EC-0DC257C7B771Q26742116-9504F52B-71D2-4B9F-9A23-8817C2A2ACCAQ26830940-250DDD2B-A20A-444A-A114-B73B76C03DE4Q28288614-101F6B5C-D85C-4DE7-A682-1DD4B25B694AQ28539293-F47883F3-9B0D-47BD-917E-E86457F0FD95Q30424954-285BB096-BEA7-40EA-8437-327CF8DC1F83Q30874197-F240EE22-272F-48BA-B52A-155789B5C5E5Q33699139-321C0285-0F01-474F-AD6B-5FEF6A04AD86Q34362275-59396A9C-25D3-4B0C-AC39-86C1EB194D72Q34407085-E140EF13-9D64-47A1-A962-E42DD573D9B8Q34769536-C49DC368-F07C-49D5-8059-58461B21D776Q35075630-07478834-C230-4E17-83FC-738057DB1C92Q35112040-73F0D0F5-F09D-4D69-BCC6-50B62C9E3D99Q35236992-53156CB3-3243-4738-852B-D53DEB4E958DQ35244854-1D078BCA-D5AE-439D-A145-905E0F8DEB54Q35987985-75F227D2-D632-4CFB-BCCD-E9128FA82B4CQ36009615-49CAB702-7495-4533-A794-08724BECFDFDQ37239363-EE5BF0D4-0256-490C-B44C-885E7F484E10Q37349124-65ECEFBC-01A8-4D7E-A8C9-8BFA95E68D44Q37687048-9884E385-5A84-4C07-AD19-41B7C5AAE15FQ37725471-CD55D516-1D2B-4A7B-953A-A284EF1CEC08Q37851076-38442565-65EF-4D31-AB16-EDFB76C01999Q37921956-2D6A851E-6B5A-470C-A31B-8F66A4515203Q37992502-4FE7D64E-92AD-4CC2-9DCD-DFED1C7DA6E9Q38590471-529B7FB4-CAFB-4110-B0DA-C1A83F50236EQ38824811-E9925F17-4644-4631-8EDE-0158546FCE09Q39017908-560BDF20-EA8F-4723-B7C7-ED5242910E23Q40289536-B9A6E15A-6023-43CF-ACC3-A51706E121D0Q42317550-6F12B605-FEB3-4364-B38B-34BF915191DDQ54400216-F3904339-538F-47E7-9B54-E0173529B0F2Q59134002-32E9718C-A9E2-43F3-9340-0BD95C5CAC3A
P2860
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
@ast
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
@en
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
@nl
type
label
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
@ast
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
@en
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
@nl
prefLabel
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
@ast
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
@en
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
@nl
P2093
P2860
P50
P356
P1433
P1476
A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas
@en
P2093
A Ramírez de Molina
C Cordón-Cardó
J J Sánchez
J Koutcher
M González-Barón
V Ramírez de Molina
P2860
P2888
P304
P356
10.1038/ONC.2009.91
P407
P577
2009-05-18T00:00:00Z
P5875
P6179
1013417983